Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s): CRDL

Healthcare

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.

TSX:CRDL - Post by User

Cardiol Therapeutics Inc

Bullboard Posts

Post by Youhillmanon Sep 26, 2020 7:59am

259 Views

Post# 31624961

Elsley Interview on FDA Approvals Phase 2 / 3 Trials

[paid promotional message] interview with Elsley yesterday about the FDA approvals.

This approval should have moved the SP much more then 19% yesterday, I'm thinking it's going to be a gradual SP climb now from here until further news is shared.

The SP should be between $5-$10 buy year end!

https://ca.paidpromotionalmessages.com/companies/news/930041/cardiol-therapeutics-receives-fda-approval-for-phase-23-covid-19-trial-with-cardiolrx-930041.html

Bullboard Posts

The top TSX healthcare stocks under $1